查看原文
其他

创业吧l上海合成生物学公司招人啦

吴红岩 医药荐客 2022-05-20


公司背景:

由国内外合成生物学领军企业高管组成,核心成员平均拥有10年以上工业界经验,业务能力涵盖菌种工程、发酵和提取工艺、放大量产、市场等。团队合计拥有超过20个合成生物学产品从头研发的商业化经验目前已完成过亿元的A轮融资。


1)Strain Engineer/Synthetic Biologist(博士,应届的也可以)

Key roles and responsibilities:

• Design and execute experiments and work plan as required by project scope, milestones and timeline; develop and guide multiple lines of investigation

• Develop methods and tools related to strain engineering

• Applies metabolic engineering and synthetic biology principles to solve potential problems in the engineering of highly efficient microbial strains. May serve in a technical leadership capacity

• May manage associates and researchers. Responsible for their professional development

• Summarize and present results of project/lab activities at internal meetings or external conferences

Requirements:

• Ph.D. in molecular biology, microbiology, biochemistry or related fields

• Experience in yeast metabolic engineering or yeast genetics is preferred

• Knowledge in fermentation, downstream process as well as analytical chemistry is a plus

• Proven experiences in strain engineering as demonstrated by publications and previously completed projects and/or developed products

• Excellent interpersonal, organizational, analytical and troubleshooting skills

• Strong communication skill for technical alignment with internal/external project partners


2)分离纯化负责人

职责描述:

负责分离纯化团队的管理;

负责微生物发酵产品(小分子为主)分离纯化方法的开发;

负责发酵产物分离纯化工艺路线的中试及技术转移;

负责和相关部门(菌株构建,发酵,生产)沟通协调,优化分离纯化工艺

任职要求:

生物工程相关专业,硕士5年以上或博士2年以相关经验

有微生物发酵产物分离纯化的经验,如膜分离,离子交换层析等小分子分离技术;

能进行中英文文章的查询和阅读,英文理解能力强;

有团队管理经验;


欢迎自荐推荐和转发分享,电话/微信:13564288425

2022年大中华区医药行业薪酬报告-更新版

诚聘首席商务官CBO-美国WFH

生物医药职位汇总-20220301

新加坡筹建CRO公司寻找创业合伙人-地点不限

分子胶初创公司招聘药理和药化(高级)总监

诚聘Chief of Staff(博士,有咨询公司背景)

艾瑞咨询:中国小分子创新药行业研究报告

一图看清新冠口服药进展20220327

江浙沪医药医疗研发想转型商务投资的看过来

欧洲公司招聘API 工艺开发和项目管理博士

波士顿RNA公司招聘免疫学和制剂人才

mRNA公司招聘临床前研发总监和计算结构生物博士

长期为以下三类机构免费发布和推广招聘信息

估值4到7亿美元,IPO只差临门一脚的Biotech老总在焦虑什么?

AI for Drug Discovery Landscape Overview 2021(应该是最详尽的报告了)

探针资本_行业研究:基于结构生物学的药物发现


您可能也对以下帖子感兴趣

文章有问题?点此查看未经处理的缓存